Compare SKYX & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKYX | MXCT |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 149.3M | 136.0M |
| IPO Year | 2014 | 2021 |
| Metric | SKYX | MXCT |
|---|---|---|
| Price | $1.17 | $1.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $5.00 | ★ $5.50 |
| AVG Volume (30 Days) | ★ 1.8M | 1.5M |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,700,948.00 | ★ $33,026,000.00 |
| Revenue This Year | $25.12 | N/A |
| Revenue Next Year | $24.18 | $18.50 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 9.78 | N/A |
| 52 Week Low | $0.95 | $0.64 |
| 52 Week High | $3.29 | $2.37 |
| Indicator | SKYX | MXCT |
|---|---|---|
| Relative Strength Index (RSI) | 57.62 | 67.23 |
| Support Level | $1.00 | $0.77 |
| Resistance Level | $1.29 | $1.33 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 92.12 | 84.32 |
SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.